Joseph Levine, MD

Original Research

Lack of Efficacy of 5 Grams Daily of Creatine in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

June 15, 2007

Alex Kaptsan, Alex Odessky, Yamima Osher, et al

Letter to the Editor

Open Study of Creatine Monohydrate in Treatment-Resistant Posttraumatic Stress Disorder

May 15, 2006

Daniela Amital, Tali Vishne, Suzana Roitman, et al

Original Research

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

December 15, 2005

Vladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al

Original Research

Single-Dose Intravenous Valproate in Acute Mania

January 1, 2004

Katrina Phrolov, Julia Applebaum, Joseph Levine, et al

Original Research

Intravenous Fosphenytoin in Acute Mania

April 15, 2003

Julia Applebaum, Joseph Levine, R. H. Belmaker

Original Research

Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants

July 1, 2001

K. N. Roy Chengappa, Radha K. Kambhampati, Kenneth Perkins, et al

Letter to the Editor

Side Effect Profile of Enteric-Coated Divalproex Sodium Versus Valproic Acid

September 30, 2000

Joseph Levine, K. N. Roy Chengappa, Haranath Parepally

Original Research

Clozapine Reduces Severe Self-Mutilation and Aggression in Psychotic Patients With Borderline Personality Disorder

July 1, 1999

K. N. Roy Chengappa, Tom Ebeling, Jasbir S. Kang, et al

Letter to the Editor

Second Thoughts About Clozapine as a Treatment for Neuroleptic-Induced Akathisia

April 15, 1998

Joseph Levine, K. N. Roy Chengappa

Lack of Efficacy of 5 Grams Daily of Creatine in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

Open Study of Creatine Monohydrate in Treatment-Resistant Posttraumatic Stress Disorder

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

Single-Dose Intravenous Valproate in Acute Mania

Intravenous Fosphenytoin in Acute Mania

Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants

Side Effect Profile of Enteric-Coated Divalproex Sodium Versus Valproic Acid

Clozapine Reduces Severe Self-Mutilation and Aggression in Psychotic Patients With Borderline Personality Disorder

Second Thoughts About Clozapine as a Treatment for Neuroleptic-Induced Akathisia

ELSEWHERE:

FOLLOW US:

Joseph Levine, MD

Lack of Efficacy of 5 Grams Daily of Creatine in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

Open Study of Creatine Monohydrate in Treatment-Resistant Posttraumatic Stress Disorder

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

Single-Dose Intravenous Valproate in Acute Mania

Intravenous Fosphenytoin in Acute Mania

Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants

Side Effect Profile of Enteric-Coated Divalproex Sodium Versus Valproic Acid

Clozapine Reduces Severe Self-Mutilation and Aggression in Psychotic Patients With Borderline Personality Disorder

Second Thoughts About Clozapine as a Treatment for Neuroleptic-Induced Akathisia

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles